JG
CLBTW

Jefferies Group’s Cellebrite DI Ltd. Warrants CLBTW Stock Holding History

Jefferies Group’s Portfolio CLBTW Stock Details CLBTW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-75,000
Closed -$132K – 2027
2021
Q4 		$132K Hold
75,000
– – ﹤0.01% 1445
2021
Q3 		$161K Buy
+75,000
New +$173K ﹤0.01% 1495

Other funds holding CLBTW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return
LSCM
Light Street Capital Management Palo Alto, California $534M AUM 59.08% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
CPM
Crescent Park Management East Palo Alto, California $29M AUM 1.79% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
ACA
Arena Capital Advisors Los Angeles, California $208M AUM 11.42% 1-Year Est. Return
TCA
Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return

Jefferies Group's CLBTW Position: Q1 2022 in Review

Jefferies Group sold out of Cellebrite DI Ltd. Warrants (CLBTW) in Q1 2022, closing a stake of 75,000 shares — an estimated $132K sold.

Jefferies Group first reported a position in CLBTW in Q3 2021 and held it in 2 quarters. The position peaked at $161K in Q3 2021. 26 funds tracked by Wall St. Rank hold CLBTW as of Q1 2022.

  • Jefferies Group reported no remaining Cellebrite DI Ltd. Warrants position as of Q1 2022 after selling out during the quarter.
  • Jefferies Group sold 75,000 Cellebrite DI Ltd. Warrants shares in Q1 2022, an estimated $132K.
  • Jefferies Group first reported a position in Cellebrite DI Ltd. Warrants in Q3 2021 and held it in 2 quarters.
  • Jefferies Group's Cellebrite DI Ltd. Warrants position peaked at $161K in Q3 2021.
  • 26 funds tracked by Wall St. Rank held Cellebrite DI Ltd. Warrants as of Q1 2022.

Based on Jefferies Group's 13F filing for Q1 2022, filed 16 May 2022.